Evidence map›Paper›PMID 36746658›Full record

ArticleThe American journal of tropical medicine and hygiene2023

A Rapid Point-of-Care Assay for Cysticercosis Antigen Detection in Urine Samples.

Luz Toribio, Sukwan Handali, Yazmin Marin, Erika Perez, Yesenia Castillo, Javier A Bustos, Seth E O'Neal, Hector H Garcia

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Luz ToribioCenter for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
Sukwan HandaliDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Yazmin MarinCysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Erika PerezCysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Yesenia CastilloCenter for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
Javier A BustosCenter for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
Seth E O'NealSchool of Public Health, Oregon Health & Sciences University-Portland State University, Portland, Oregon.
Hector H GarciaCenter for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
Instituto Nacional de Enfermedades Neoplásicas · PEUniversidad Peruana Cayetano Heredia · PECenters for Disease Control and Prevention · USInstituto Nacional de Ciencias NeurológicasPortland State University · USPrisma · PE

Funding

Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
Urine Screening for Early Detection of Subarachnoid NeurocysticercosisR01NS103623 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GARCIA, HECTOR HUGO, O'NEAL, SETH E · 2018 to 2023
$3.0M
Scientific CoreU19AI129909 · NIAID · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · 2017 to 2021
$2.8M
FIC NIH HHS D43 TW001140NIAID NIH HHS U19 AI129909NINDS NIH HHS R01 NS103623
6 · The paper itself

Abstract

We report a proof-of-concept study using a dipstick assay to detect Taenia solium antigen in urine samples of 30 patients with subarachnoid neurocysticercosis and 10 healthy control subjects. Strips were read in blind by two readers. The assay detected antigen in 29 of 30 cases and was negative in all 10 control samples. Although this study was performed in samples from individuals with subarachnoid neurocysticercosis who likely had high circulating antigen levels, it provides the proof of concept for a functional urine antigen point-of-care assay that detects viable cysts. Such an assay could serve to support a clinical diagnosis of suspect neurocysticercosis or to identify patients at risk of developing severe disease in areas where medical resources are limited, providing evidence to refer these individuals for imaging and specialized care as needed.

Indexed as

CysticercosisNeurocysticercosisTaenia soliumAnimalsAntigens, HelminthEnzyme-Linked Immunosorbent AssayHumansPoint-of-Care SystemsAntigens, Helminth

Identifiers

PMID36746658
PMCPMC9978566
OpenAlexW4319312449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.